Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Invex Therapeutics Ltd. ( (AU:IXC) ) just unveiled an update.
Invex Therapeutics Ltd. has announced the appointment of Mr. Simon Llewellyn Owen as a new director, effective November 10, 2025. The announcement indicates that Mr. Owen currently holds no relevant interests in securities, which may suggest a fresh perspective in his role, potentially impacting the company’s strategic direction and stakeholder interests.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative therapies for unmet medical needs.
Average Trading Volume: 67,890
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$8.64M
Find detailed analytics on IXC stock on TipRanks’ Stock Analysis page.